8-K
filed February 2, 2024, 6:59 PM ET
ticker ASMB
CIK 0001426800
other material
confidence high
sentiment neutral
materiality 0.60
Assembly Biosciences stockholders approve reverse stock split; Board sets ratio at 1-for-12
ASSEMBLY BIOSCIENCES, INC.
- Stockholders approved a range of 1-for-7 to 1-for-17 reverse stock split; Board selected 1-for-12 ratio.
- Approval of share issuance to Gilead Sciences under October 2023 Stock Purchase Agreement (16.2M votes for).
- Reverse split expected to be effectuated as soon as practicable after the January 31, 2024 special meeting.
- Adjournment proposal approved with 28M votes for, 9.7M against.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ASSEMBLY BIOSCIENCES, INC. shareholders approved Reverse stock split at ratio from 1-for-7 to 1-for-17 at the 2024-01-31 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
The stockholders approved a series of alternate amendments to the Company's Sixth Amended and Restated Certificate of Incorporation to effect, at the discretion of the Company's Board of Directors (the "Board"), a reverse stock split of the Company's common stock at a ratio to be determined by the Board within a range of 1-for-7 to 1-for-17 (or any number in between) without reducing the authorized number of shares of the common stock.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ASSEMBLY BIOSCIENCES, INC. shareholders approved Adjournment of the Special Meeting to solicit additional proxies if necessary at the 2024-01-31 meeting.
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
The stockholders approved an adjournment of the Special Meeting to a later date or dates, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the foregoing proposals.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ASSEMBLY BIOSCIENCES, INC. shareholders approved Issuance of shares of common stock to Gilead Sciences, Inc. pursuant to Nasdaq Listing Rules 5635(a) and 5635(b) at the 2024-01-31 meeting.
- Outcome
- passed
- Meeting
- 2024-01-31
Exact text from the filing
The stockholders approved, subject to certain conditions, the issuance of shares of common stock to Gilead Sciences, Inc. ("Gilead") pursuant to Nasdaq Listing Rules 5635(a) and 5635(b).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.